Analyst Ratings for Moonlake Immunotherapeutics (MLTX)
MLTX Rating Summary
MLTX Price Target Summary
- Highest: $80.00 (Wedbush)
- Lowest: $5.00 (Citi)
- Average: $30.64
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.64 (+59.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$30.64 (+59.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/23/2026 | Wolfe Research | Andy Chen | Upgrade | Outperform (Peerperform) |
24.00 (12.00) |
16.27 (19.21) |
18.07% | Details |
| 3/19/2026 | Rothschild Redburn | Qize Ding | Upgrade | Buy (Neutral) |
40.00 (12.00) |
16.77 (19.21) |
14.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
